This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Virtual Reality Hypnosis for Chronic Pain Reduction (VRHChP)

This study has been completed.
Sponsor:
Collaborator:
National Institute of General Medical Sciences (NIGMS)
Information provided by (Responsible Party):
Shelley A. Wiechman, University of Washington
ClinicalTrials.gov Identifier:
NCT01099657
First received: April 1, 2010
Last updated: May 10, 2017
Last verified: May 2017
  Purpose
We would like to determine how well hypnosis works when induced through virtual reality medium for patients who have suffered a major burn injury in the past two years and suffer from chronic pain. These patients are coming back to the outpatient burn and plastic clinic at Harborview Medical Center for routine follow-up. We think that patients will find VR-Hypnosis interesting, and it will help them relax and feel less pain.

Condition Intervention
Burns Behavioral: Virtual Reality Hypnosis for chronic pain Behavioral: Virtual Reality Distraction for Chronic Pain

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Treatment
Official Title: Virtual Reality Hypnosis for Chronic Pain Reduction

Resource links provided by NLM:


Further study details as provided by Shelley A. Wiechman, University of Washington:

Primary Outcome Measures:
  • Pain and anxiety [ Time Frame: pre and post VR and then up to one month ]
    The subjects will answer questions regarding pain and anxiety at the time of their clinic visit, before and after experiencing virtual reality. Then the subject will be followed for up to one month.


Enrollment: 10
Study Start Date: June 2007
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Virtual Reality Hypnosis
Virtual Reality Hypnosis for chronic pain
Behavioral: Virtual Reality Hypnosis for chronic pain
At the time of their clinic visit,the subject will answer pain and anxiety questionnaires before experiencing Virtual Reality Hypnosis. After VRH, the will again answer Pain and anxiety questionnaires.
Experimental: Virtual Reality Distraction
Virtual Reality Distraction for Chronic Pain
Behavioral: Virtual Reality Distraction for Chronic Pain
At the time of their clinic visit,the subject will answer pain and anxiety questionnaires before experiencing Virtual Reality Distraction. After VRD, the will again answer Pain and anxiety questionnaires.

  Eligibility

Ages Eligible for Study:   13 Years to 75 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 13 - 75 years
  • Able to complete subjective evaluations of pain
  • English-speaking
  • Able to communicate orally

Exclusion Criteria:

  • Age less than 13 years or greater than 75 years
  • Incapable of indicating subjective evaluation of pain
  • Non-English-speaking (Virtual Reality Hypnosis only available in English)
  • Demonstrating delirium, psychosis, or Organic Brain Disorder
  • Unable to communicate verbally
  • Significant developmental disability
  • Extreme susceptibility to motion sickness
  • Significant head/or neck injury
  • Pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01099657

Locations
United States, Washington
Harborview Medical Center
Seattle, Washington, United States, 98104
Sponsors and Collaborators
University of Washington
National Institute of General Medical Sciences (NIGMS)
  More Information

Responsible Party: Shelley A. Wiechman, Associate Professor, Rehabilitative Medicine, University of Washington
ClinicalTrials.gov Identifier: NCT01099657     History of Changes
Other Study ID Numbers: 31498
Study First Received: April 1, 2010
Last Updated: May 10, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Chronic Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on August 18, 2017